格隆汇2月5日丨翔宇医疗(688626.SH)在互动平台表示，公司基于自主研发和具备行业内较全体系的康 复装备基础，可快速实现"脑机接口技术+自有康复设备"的深度融合，提供脑机接口赋能的整体解决方 案，相关产品已进入600多家三甲医院，持续保持公司在行业内的竞争优势。 但招投标和销售等具有滞 后性，截至2025年末，公司脑机接口相关产品实现营收占比较小。 ...

（编辑 任世碧） 证券日报网讯 2月4日，翔宇医疗在互动平台回答投资者提问时表示，2025年12月，翔宇工业旅游景区 获评国家4A级旅游景区，标志着景区在旅游资源开发、服务品质提升、文化内涵挖掘等方面获得认 可，也为安阳"中国康复设备之都"品牌再添文旅亮色。 ...

Core Viewpoint - The rehabilitation industry is viewed as a "golden track" with significant growth potential, driven by brain-computer interface (BCI) technology, which is expected to reshape the industry landscape [1] Group 1: Technological Innovation - The company focuses on three cutting-edge areas: brain-computer interfaces, rehabilitation robots, and AI medical technology, with BCI technology accelerating commercialization [2] - A comprehensive product matrix for rehabilitation robots has been established, with plans to launch 5-6 new products by 2026, including various specialized robots [2][4] - The company has initiated a brain science laboratory and developed five technical platforms to enhance its BCI technology, achieving compatibility between EEG devices and rehabilitation equipment [4] Group 2: Research and Development Investment - The company plans to maintain R&D investment at over 20% of revenue for the next 3-5 years, with more than 30% allocated to frontier technology research [5] - In the first three quarters of 2025, R&D investment reached approximately 49.09 million yuan, a year-on-year increase of 27.67%, accounting for 27.58% of quarterly revenue [5] Group 3: Market Transformation - The company has partnered with over 600 leading hospitals to establish BCI rehabilitation treatment and clinical research centers, enhancing treatment precision and effectiveness [6] - The company is transitioning from passive to active rehabilitation models, leveraging BCI technology to empower various rehabilitation products [6] Group 4: International Expansion - The company is accelerating its international market strategy, with overseas sales expected to double in 2024 compared to 2023, aiming for international revenue to account for over 30% by 2030 [7] - The company is pursuing compliance certifications such as EU CE and US FDA to facilitate international market entry and is exploring partnerships and acquisitions to enhance its global presence [7] Group 5: Ecosystem Development - The company is focused on building a comprehensive rehabilitation ecosystem, emphasizing the integration of BCI technology into rehabilitation devices, which is seen as essential for future products [8] - The trend towards lightweight, portable, and home-based rehabilitation devices is expected to drive significant growth in the home rehabilitation market [8] Group 6: Industry Integration - The company plans to strengthen its supply chain for core components and aims to execute 3-5 mergers and acquisitions between 2026 and 2030 to integrate high-growth startups [9] - The company targets to establish chain rehabilitation hospitals featuring BCI and rehabilitation robots, with a goal of achieving over 20% of service revenue by 2030 [9]

Core Viewpoint - The rehabilitation industry is viewed as a "golden track" with significant growth potential, driven by brain-computer interface (BCI) technology, which is expected to reshape the industry landscape [1] Group 1: Technological Innovation - The company focuses on three cutting-edge areas: brain-computer interfaces, rehabilitation robots, and AI medical technology, with BCI technology accelerating commercialization [2] - A comprehensive product matrix in rehabilitation robotics has been established, with plans to launch 5-6 medical device registrations by 2026 [2] - The company has initiated a brain science laboratory and developed five technical platforms to enhance BCI technology integration with rehabilitation equipment [3] - Continuous R&D investment is planned to remain above 20% of revenue over the next 3-5 years, with a significant portion allocated to frontier technology research [4] Group 2: Market Transformation - The company has partnered with over 600 leading hospitals to establish BCI rehabilitation treatment and clinical research centers, aiming to create regional treatment benchmarks [5] - The integration of BCI technology into multi-joint exoskeleton robots and various rehabilitation products is expected to enhance treatment precision and effectiveness [6] - A dual strategy of deepening medical institution engagement while expanding into outpatient markets is being implemented, targeting public hospitals, private hospitals, and rehabilitation institutions [6] Group 3: International Expansion - The company is accelerating its international business, with overseas sales expected to double in 2024 compared to 2023, aiming for international revenue to account for over 30% by 2030 [6][7] - Compliance with international certification standards, such as EU CE and US FDA, is being prioritized to facilitate market entry [7] Group 4: Ecosystem Development - The company is focused on building a comprehensive rehabilitation ecosystem, emphasizing the importance of BCI technology in future rehabilitation devices [8] - The trend towards lightweight, portable, and home-based rehabilitation devices is noted, with a vision to integrate rehabilitation equipment into everyday household items [8] Group 5: Industry Integration - Strengthening the supply chain for core components like chips and sensors is a priority, along with plans for mergers and acquisitions to consolidate industry resources [9] - The company aims to establish chain rehabilitation hospitals featuring BCI and rehabilitation robotics, targeting a service revenue contribution of over 20% by 2030 [9]

Core Viewpoint - The rehabilitation industry is viewed as a "golden track" with significant growth potential, and brain-computer interface (BCI) technology is emerging as a disruptive force reshaping the industry landscape [1] Group 1: Technological Innovation - The company focuses on three cutting-edge areas: brain-computer interfaces, rehabilitation robots, and AI medical technology, with BCI technology accelerating commercialization [2] - A comprehensive product matrix in rehabilitation robotics has been established, with plans to launch 5-6 medical device registrations by 2026 [2] - The company has initiated a brain science laboratory and developed five technical platforms to enhance BCI technology integration with rehabilitation equipment [3] - Continuous R&D investment is planned to remain above 20% of revenue over the next 3-5 years, with a significant portion allocated to frontier technology research [4] Group 2: Market Transformation - The company has partnered with over 600 leading hospitals to establish BCI rehabilitation treatment and clinical research centers, enhancing treatment precision and effectiveness [5] - A dual strategy of deepening medical institution engagement and expanding outpatient markets is being implemented, targeting various sectors including private hospitals and rehabilitation institutions [5] - International market expansion is accelerating, with a goal to double overseas sales in 2024 and achieve over 30% of revenue from international markets by 2030 [5][6] Group 3: Ecosystem Development - The company is focused on building a comprehensive rehabilitation ecosystem, emphasizing the importance of BCI technology in future rehabilitation devices [7] - There is a shift towards lightweight, portable, and home-based rehabilitation devices, with a vision to integrate rehabilitation equipment into everyday household items [7] - Industry chain integration is a key strategy for enhancing competitiveness, with plans for mergers and acquisitions to consolidate high-growth startups and expand rehabilitation services [8]

Core Insights - The rehabilitation industry is viewed as a "golden track" with significant growth potential, driven by brain-computer interface (BCI) technology, which is expected to reshape the industry landscape [1][4]. Group 1: Technological Innovation - The company focuses on three cutting-edge areas: brain-computer interfaces, rehabilitation robots, and AI medical technology, with BCI technology accelerating commercialization [1][2]. - A comprehensive product matrix for rehabilitation robots has been established, with plans to obtain medical device registration for 5-6 products by 2026, including various types of therapeutic robots [1][2]. - The company has initiated a dedicated research platform to enhance compatibility between rehabilitation equipment and BCI algorithms, emphasizing the importance of technical collaboration [2]. Group 2: Research and Development Investment - The company plans to maintain R&D investment at over 20% of revenue for the next 3-5 years, with more than 30% allocated to frontier technology research [3]. - In the first three quarters of 2025, R&D investment reached approximately 49.09 million yuan, a year-on-year increase of 27.67%, accounting for 27.58% of quarterly revenue [3]. Group 3: Market Expansion and Strategy - The company has established partnerships with over 600 leading hospitals in China to create centers for BCI rehabilitation treatment and clinical research, enhancing its market penetration [3]. - A dual strategy of deepening relationships with medical institutions while expanding into outpatient markets is being employed, targeting private hospitals, elderly care facilities, and specialized sectors [3][4]. Group 4: International Market Development - The international business of rehabilitation equipment is experiencing rapid growth, with plans to double sales in 2024 compared to 2023 and aim for over 30% of revenue from international markets by 2030 [4]. - The company is working on compliance certifications such as EU CE and US FDA to facilitate international market entry and is exploring partnerships for overseas expansion [4]. Group 5: Ecosystem Development - The company is focused on building a comprehensive rehabilitation ecosystem, leveraging BCI technology as a core driver for industry transformation [4][5]. - There is a shift towards lightweight, portable, and home-based rehabilitation devices, with a vision to integrate rehabilitation equipment into everyday household items [5]. - The company plans to enhance its supply chain for core components and aims to execute 3-5 mergers and acquisitions between 2026 and 2030 to consolidate industry resources [5].

Summary of Conference Call for Kefu Medical and Lizhi Intelligent Industry and Company Overview - The conference call primarily discusses the collaboration between Kefu Medical and Lizhi Intelligent in the non-embedded brain-machine rehabilitation sector, aiming to integrate their strengths for business synergy in both B-end (hospitals) and C-end (consumers) markets [2][4]. Key Points and Arguments Collaboration and Market Strategy - Kefu Medical and Lizhi Intelligent are working together to enhance product value by combining brain-controlled rehabilitation robots with existing products, such as integrating sleep devices with ventilators [2][10]. - The partnership aims to leverage Kefu Medical's market data to iterate AI algorithms, creating a closed-loop system that enhances product profitability and brand reputation [2][11]. Technological Advancements - Lizhi Intelligent has developed a comprehensive technology chain in brain-machine interface technology, including sensor data acquisition, algorithm decoding, and execution control, which has been successfully applied in rehabilitation robots [6][8]. - The focus is on non-invasive brain-machine interface technology, which has broad application prospects in home rehabilitation, particularly for sleep management, pain management, and Parkinson's disease [5][16]. Market Demand and Policy Support - The aging population in China, which reached a rate of 22% in 2025, is driving the demand for home rehabilitation solutions [2][11]. - There is a high clinical demand for brain-machine interface products, with over 500 million yuan in orders already secured [7][14]. - At least 15 provinces in China have introduced supportive policies for the brain-machine interface industry, enhancing institutional purchasing enthusiasm [15][18]. Financial and Investment Insights - Kefu Medical has made significant investments in Lizhi Intelligent, with plans to gradually increase its shareholding to achieve business synergy [4][22]. - The company is also collaborating with Philips, with a new team established to develop a series of products expected to launch by the end of Q2 2026 [24][25]. Future Outlook - The brain-machine interface industry is in its early stages, with a projected development window of 5 to 10 years, driven by technological advancements and the growing demand from an aging population [18]. - Kefu Medical is focused on expanding its product lines and enhancing its international capabilities, with plans for an IPO in Hong Kong nearing completion [27][28]. Additional Important Content - Lizhi Intelligent's collaboration with South China University of Technology aims to foster talent and technology integration, enhancing product development and iteration [12]. - The company is also exploring invasive brain-machine interface technologies, although these are still in the research phase [12][16]. - The competitive advantage lies in providing practical, clinically applicable solutions that meet diverse medical needs, ensuring revenue generation through genuine partnerships rather than free distribution [19].

Group 1: Company Announcements - Anheng Information's shareholder Alibaba Venture Capital plans to reduce its stake by no more than 1% [1] - Blue Special Optics intends to raise no more than 1.055 billion yuan through a private placement for various projects [3] - Ding Tong Technology plans to issue convertible bonds to raise no more than 930 million yuan for expansion projects [4] - Hu Silicon Industry expects a net loss of 1.28 billion to 1.53 billion yuan for 2025, with a decline in the price of 300mm semiconductor wafers impacting revenue [2] - Aerospace Hongtu anticipates a net loss for 2025 due to declining main business revenue and project gross margin [4] - Trina Solar expects a net loss for 2025 [4] - JinkoSolar also forecasts a net loss for 2025 [4] - Xiangyu Medical expects to launch 5-6 AI rehabilitation robot products by 2026 [4] Group 2: Industry Developments - Three departments held a meeting to regulate the electric vehicle industry, emphasizing the need to resist disorderly price wars and ensure fair competition [1] - Shanghai aims to achieve large-scale implementation of high-level autonomous driving applications by 2027, with a focus on innovation and industry competitiveness [2] Group 3: Financial Performance Forecasts - Daqing Energy expects a net loss for 2025, although the loss is projected to be narrower than the previous year [9] - Shengke Communication forecasts a net loss of 120 million to 160 million yuan for 2025, with revenue growth but increased R&D costs impacting profitability [10] - Qin Chuan Internet of Things anticipates a net loss of 100 million to 120 million yuan for 2025, driven by declining sales and high R&D expenses [11] - Jinbo Co. expects a net loss for 2025 [12] - Qi Anxin also forecasts a net loss for 2025 [13]

Core Viewpoint - Chengyitong's rehabilitation segment, Longzhijie, offers a comprehensive elderly rehabilitation solution suitable for community elderly service centers and home care scenarios, including equipment supply, technical support, and training services [2] Group 1: Product Offerings - Longzhijie provides a variety of products for rehabilitation, including exercise rehabilitation devices for elderly limb function recovery, such as active and passive rehabilitation instruments, limb coordination systems, and balance assessment and training systems [2] - The product range also includes physical therapy items like various electrical stimulation products, pneumatic limb products, and magnetic stimulation products [2] - Additionally, auxiliary products are offered, such as training beds and overhead transfer systems [2] Group 2: R&D and Market Understanding - Longzhijie possesses strong research and development capabilities, having established a mature system for R&D, production, sales, and service [2] - The company has a deep understanding of the rehabilitation needs of the elderly population due to years of industry experience [2]

Core Insights - Anyang is at a historical crossroads, showcasing a blend of tradition and modernity, with significant advancements in various industries, particularly in the drone sector and high-end manufacturing materials [1] - The city is set to continue its development journey, focusing on the construction of "one highland, one area, and three centers" [1] Group 1: Low-altitude Economy Development - The release of the "Guidelines for Urban Low-altitude Air Traffic Management" and the "Action Plan for Promoting High-quality Development of Low-altitude Economy (2025-2027)" establishes a solid institutional foundation for Anyang's low-altitude economy [2] - The city is implementing a series of supportive policies, including tax reductions and financial subsidies for aviation-related enterprises, to encourage increased R&D investment [2] - Infrastructure development is accelerating with the establishment of general airports and drone take-off and landing points, enhancing the low-altitude flight service guarantee system [2] Group 2: Industrial Transformation and Innovation - Anyang is focusing on breaking free from its reliance on traditional steel industries by fostering new productive forces through technological innovation and advanced manufacturing [5] - The city is enhancing the integration of industrial and innovation chains, aiming for a dual improvement in scale and quality of industrial clusters [5][6] - The rise of strategic emerging industries is reflected in the increase of their added value to 19%, showcasing the strengthening of Anyang's "intelligent manufacturing" framework [6] Group 3: Cultural and Historical Significance - The city celebrated the 60th anniversary of the Hongqi Canal, emphasizing the enduring spirit of self-reliance and hard work [7] - The 2025 China (Anyang) International Chinese Character Conference highlighted the cultural heritage of Anyang, attracting over 50 international guests to explore the mysteries of Chinese characters [7] - Anyang's commitment to cultural transmission is evident through immersive reporting and the creation of cultural products that resonate with its historical significance [7] Group 4: Achievements in Healthcare and Technology - The 10th Rehabilitation Equipment Expo showcased innovative products from leading domestic companies, such as Xiangyu Medical, highlighting Anyang's strength in intelligent manufacturing [4] - The city is witnessing a transformation in the healthcare sector with the introduction of smart rehabilitation devices and emergency drones, contributing to the overall development of the low-altitude economy [6][8]